Canada adds “Capillary Leak Syndrome” to contraindications for Astra Zeneca
Health Canada, the Canadian pharmaceutical regulator, is updating contraindications for the Oxford-AstraZeneca and COVISHIELD COVID-19 vaccines by adding capillary leak syndrome as a potential side effect of vaccination. Among other things, the agency contraindicates the vaccine to those who already suffer from this disease which, in the idiopathic form, is called Clarkson's disease.
Leaky capillary syndrome is a very rare and serious condition that causes fluid loss from small blood vessels (capillaries), which can cause swelling of the arms and legs, sudden weight gain, low blood pressure, thickening of the blood and low blood levels of the blood protein albumin.
Health Canada and the Public Health Agency of Canada have been monitoring the condition since it was raised as a potential safety concern by the European Medicines Agency in April.
Earlier this month, the EU medicines regulatory authority said it looked at cases of six people who had capillary leak syndrome after receiving an injection of the AstraZeneca vaccine, out of 78 million doses of the AstraZeneca and COVISHIELD vaccines administered in Europe and the UK as of 27 May 2021.
There was a case of capillary leak syndrome following vaccination with the AstraZeneca or COVISHIELD COVID-19 vaccine reported in Canada on June 11.
Another contraindication for the Astra Zeneca vaccine, the name of which has already been known for problems with blood clots. In short, the panacea for covid-19 is not immune to risks, yet I do not think you have heard this story on TV.
Thanks to our Telegram channel you can stay updated on the publication of new articles of Economic Scenarios.
The article Canada adds the “Capillary Leak Syndrome” to the contraindications for Astra Zeneca comes from ScenariEconomici.it .
This is a machine translation of a post published on Scenari Economici at the URL https://scenarieconomici.it/il-canada-aggiunge-l-sindrome-da-permeabilita-capillare-alle-controindicazioni-per-astra-zeneca/ on Sat, 03 Jul 2021 20:41:28 +0000.